Prostaglandin Synthetase Inhibitors: Drugs Which Affect Arachidonic Acid Metabolism

References

• Baenziger N. L., Dillender M. J., Majerus P. W. Cultured human skin fibroblasts and arterial cells produce a labile platelet-inhibitory prostaglandin. Biochem Biophys Res Commun 1977; 78: 294
   PubMed Web of Science ®Google Scholar
• Blackwell G. J., Flower R. J. 1-phenyl-3-pyrazolidone: an inhibitor of cyclo-oxygenase and lipoxygenase pathways in lung and platelets. Prostaglandins 1978; 16: 417
   PubMed Web of Science ®Google Scholar
• Blackwell G. J., Flower R. J., Russell-Smith N., Salmon J. A., Thorogood P. B., Vane J. R. Prostacyclin is produced in whole blood. Br J Pharmacol 1978; 64: 436P
   PubMed Web of Science ®Google Scholar
• Di Rosa M., Capasso F., Mascola N. Inhibition of prostaglandin synthesis in vitro by rat serum. Bologna 1978, Proceedings of International Congress of Inflammation in press
   Google Scholar
• Downing D. T., Ahern D. G., Bachta M. Enzyme inhibition by acetylenic compounds. Biochem Biophys Res Commun 1970; 40: 218
   PubMed Web of Science ®Google Scholar
• Ferreira S. H. Prostaglandins, aspirin-like drugs and analgesia. Nature (New Biol) 1972; 240: 200
   PubMedGoogle Scholar
• Flower R. J., Blackwell G. J. The importance of phospholipase A2 in prostaglandin biosynthesis. Biochem Pharmacol 1976; 25: 285
   PubMed Web of Science ®Google Scholar
• Flower R. J., Vane J. R. Inhibition of prostaglandin biosynthesis. Biochem Pharmacol 1974; 23: 1439
   PubMed Web of Science ®Google Scholar
• Gorman R. R., Bundy G. L., Peterson D. C., Sun F. F., Miller O. V., Fitzpatrick F. A. Inhibition of human platelet thromboxane synthetase by 9, 11, azaprosta-5, 13-dienoic acid. Proc Natl Acad Sci (USA) 1977; 74: 4007
   PubMed Web of Science ®Google Scholar
• Gryglewski R. J. Steroid hormones, anti-inflammatory steroids and prostaglandins. Pharmacol Res Commun 1976; 8: 337
   PubMedGoogle Scholar
• Gryglewski R. J., Zmuda A., Korbut R., Krecioch E., Beiron K. Selective inhibition of thromboxane A2 biosynthesis in blood platelets. Nature 1977; 267: 627
   PubMed Web of Science ®Google Scholar
• Hamberg M., Samuelsson B. Detection and isolation of an endoperoxide intermediate in prostaglandin biosynthesis. Proc Natl Acad Sci (USA) 1973; 70: 899
   PubMed Web of Science ®Google Scholar
• Hamberg M., Samuelsson B. Prostaglandin endoperoxides. Novel transformation of arachidonic acid in human platelets. Proc Natl Acad Sci (USA) 1974; 71: 3400
   PubMed Web of Science ®Google Scholar
• Hamberg M., Svensson J., Samuelsson B. Thromboxanes: A new group of biologically active compounds derived from prostaglandin endoperoxides. Proc Natl Acad Sci (USA) 1975; 72: 2994
   PubMed Web of Science ®Google Scholar
• Higgs E. A., Moncada S., Vane J. R. Inflammatory effects of prostacyclin and 6-oxo-PGF1α in the rat paw. Prostaglandins 1978; 16: 153
   Google Scholar
• Kulkarni P. S., Eakins K. E. N-0164 inhibits generation of thromboxane A2-like activity from prostaglandin endoperoxides by human platelet microsomas. Prostaglandins 1976; 12: 465
   PubMedGoogle Scholar
• Lewis G. P., Piper P. J. Inhibition of release of prostaglandins as an explanation of some of the actions of anti-inflammatory corticosteroids. Nature 1975; 254: 308
   PubMed Web of Science ®Google Scholar
• Main I. H. M., Whittle B. J. R. The effects of E and A prostaglandins on gastric mucosal blood flow and acid secretion in the rat. Br J Pharmacol 1973; 49: 428
   PubMed Web of Science ®Google Scholar
• Main I. H. M., Whittle B. J. R. Investigation of the vasodilator and antisecretory role of prostaglandins in the rat gastric mucosa by use of non-steroidal anti-inflammatory drugs. Br J Pharmacol 1975; 53: 217
   PubMed Web of Science ®Google Scholar
• Moncada S., Bunting S., Mullane K., Thorogood P., Vane J. R., Raz A., Needleman P. Imidazole: A selective inhibitor of thromboxane synthetase. Prostaglandins 1977; 13: 611
   PubMedGoogle Scholar
• Moncada S., Ferreira S. H., Vane J. R. Prostaglandins, aspirin-like drugs and the oedema of inflammation. Nature 1973; 246: 217
   PubMed Web of Science ®Google Scholar
• Moncada S., Gryglewski R., Bunting S., Vane J. R. An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation. Nature 1976; 263: 663
   PubMed Web of Science ®Google Scholar
• Moncada S., Gryglewski R. J., Bunting S., Vane J. R. A lipid peroxide inhibits the enzyme in blood vessel microsomes that generates from prostaglandin endoperoxides the substance (Prostaglandin X) which prevents platelet aggregation. Prostaglandins 1976; 12: 715
   PubMed Web of Science ®Google Scholar
• Moncada S., Salmon J. A., Vane J. R., Whittle B. J. R. Formation of prostacyclin (PGI2) and its product, 6-oxo-PGF1α by the gastric mucosa of several species. J Physiol 1977; 275: 4
   Google Scholar
• Moncada S., Vane J. R. Unstable metabolites of arachidonic acid and their role in haemostasis and thrombosis. Br Med Bull 1978; 34: 129
   PubMed Web of Science ®Google Scholar
• Nijkamp F. P., Moncada S., White H. L., Vane J. R. Diversion of prostaglandin endoperoxide metabolism by selective inhibition of thromboxane A2 biosynthesis in the lung, spleen and platelets. Eur J Pharmacol 1977; 44: 179
   PubMed Web of Science ®Google Scholar
• Omini C., Pasargiklian R., Folco G. C., Fano M., Berti F. Pharmacological activity of PGI2 and its metabolite 6-oxo-PGF1α on human uterus and fallopian tubes. Prostaglandins 1978; 15: 1045
   Google Scholar
• Pickles V. R., Hall W. J., Best F. A., Smith G. N. Prostaglandins in endometrium and menstrual fluid from normal and dysmenorrhoeic subjects. J Obstet Gynaecol Br Commonw 1965; 72: 185
   PubMedGoogle Scholar
• Piper P. J., Vane J. K. Release of additional factors in anaphylaxis and its antagonism by anti-inflammatory drugs. Nature 1969; 223: 29
   PubMed Web of Science ®Google Scholar
• Robert A. Effects of prostaglandins on the stomach and intestine. Prostaglandins 1974; 6: 523
   PubMedGoogle Scholar
• Saeed S. A., McDonald-Gibson W. J., Cuthbert J., Copas J. L., Schneider C., Gardiner P. J., Butt N. M., Collier H. O. J. Endogenous inhibitor of prostaglandin synthetase. Nature 1977; 270: 32
   PubMed Web of Science ®Google Scholar
• Turner S. R., Tainer J. A., Lynn W. S. Biogenesis of chemotactic molecules by the arachidonate lipoxygenase system of platelets. Nature 1975; 257: 580
   Google Scholar
• Vane J. R. Inhibition of prostaglandin biosynthesis as a mechanism of action of aspirin-like drugs. Nature (New Biol) 1971; 231: 232
   PubMedGoogle Scholar
• Vane J. R. The mode of action of aspirin and similar compounds. J Allergy Clin Immunol 1977; 58: 691
   Google Scholar
• Vane J. R. Inhibitors of prostaglandin, prostacyclin and thromboxane synthesis. Advances in Prostaglandin and Thromboxane Research, F. Coceani, P. M. Olley. Raven Press, New York 1978; Vol. 4: 27
   Google Scholar
• Williams T. J., Morley J. Prostaglandins as potentiators of increased vascular permeability in inflammation. Nature 1973; 246: 215
   PubMed Web of Science ®Google Scholar
• Williams T. J., Peck M. J. Role of prostaglandin-mediated vasodilatation in inflammation. Nature 1977; 270: 530
   PubMed Web of Science ®Google Scholar
• Whittle B. J. R. Relationship between the prevention of rat gastric erosions and the inhibition of acid secretion by prostaglandins. Eur J Pharmacol 1976; 40: 233
   PubMed Web of Science ®Google Scholar
• Whittle B. J. R. Potential endogenous inhibitor of prostaglandin synthetase in plasma: failure to inhibit cyclo-oxygenase in platelets and the gastric mucosa. J Pharm Pharmacol 1978; 30: 467
   PubMed Web of Science ®Google Scholar
• Whittle B. J. R., Boughton-Smith N. K., Moncada S., Vane J. R. Actions of prostacyclin (PGI2) and its product 6-oxo-PGF1α on the rat gastric mucosa in vivo and in vitro. Prostaglandins 1978; 15: 955
   PubMedGoogle Scholar
• Whittle B. J. R., Mugridge K. G., Moncada S. Use of the rabbit transverse stomach-strip to identify and assay prostacyclin, PGA2, PGD2 and other prostaglandins. Eur J Pharmacol 1979, in press
   Google Scholar
• Whittle B. J. R., Moncada S., Vane J. R. Comparison of the effects of prostacyclin (PGI2), prostaglandin E1 and D2 on platelet aggregation in different species. Prostaglandins 1978; 16: 373
   PubMed Web of Science ®Google Scholar
• Whittle B. J. R., Boughton-Smith N. K., Moncada S., Vane J. R. The relative activity of prostacyclin (PGI2) and a stable analogue 6β-PGI1 on the gastrointestinal and cardiovascular systems. J Pharm Pharmacol 1978; 30: 597
   Google Scholar